GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases.
More Information Supplier Page
Ciclesonide(RPR251526) is a glucocorticoid used for the treatment of obstructive airway diseases.
More Information Supplier Page
Ciclesonide(RPR251526) is a glucocorticoid used for the treatment of obstructive airway diseases.
More Information Supplier Page Ciclesonide(RPR251526) is a glucocorticoid used for the treatment of obstructive airway diseases.
More Information Supplier Page 
Ciclesonide(RPR251526) is a glucocorticoid used for the treatment of obstructive airway diseases.
More Information Supplier Page
Prucalopride is a selective, high-affinity 5-HT4A/4B receptor agonist (Ki: 2.5/8 nM). It has >290-fold selectivity for 5-HT4A/4B receptor than other 5-HT receptor subtypes.
More Information Supplier Page
Prucalopride is a selective, high-affinity 5-HT4A/4B receptor agonist (Ki: 2.5/8 nM). It has >290-fold selectivity for 5-HT4A/4B receptor than other 5-HT receptor subtypes.
More Information Supplier Page
Robenidine hydrochloride is an anticoccidial agent mainly used in poultry.
More Information Supplier Page
Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, and Flt3 (IC50s: 0.035, 1.3, 4.6, 7 and 11.3 nM).
More Information Supplier Page
Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, and Flt3 (IC50s: 0.035, 1.3, 4.6, 7 and 11.3 nM).
More Information Supplier Page 
